| 000 | 01904 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516015602.0 | ||
| 264 | 0 | _c20110425 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1879-0887 | ||
| 024 | 7 |
_a10.1016/j.radonc.2010.11.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTao, Yungan | |
| 245 | 0 | 0 |
_aA phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma. _h[electronic resource] |
| 260 |
_bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology _cJan 2011 |
||
| 300 |
_a42-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aCarcinoma, Squamous Cell |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aSquamous Cell Carcinoma of Head and Neck |
| 700 | 1 | _aRezaï, Keyvan | |
| 700 | 1 | _aBrain, Etienne | |
| 700 | 1 | _aEtessami, Atoussa | |
| 700 | 1 | _aLusinchi, Antoine | |
| 700 | 1 | _aTemam, Stephane | |
| 700 | 1 | _aUrien, Saik | |
| 700 | 1 | _aVan, Marie-Louise Vo | |
| 700 | 1 | _aVauzelle-Kervroedan, Françoise | |
| 700 | 1 | _aLokiec, François | |
| 700 | 1 | _aDaly-Schveitzer, Nicolas | |
| 700 | 1 | _aBourhis, Jean | |
| 773 | 0 |
_tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology _gvol. 98 _gno. 1 _gp. 42-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.radonc.2010.11.008 _zAvailable from publisher's website |
| 999 |
_c20465039 _d20465039 |
||